Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
124 participants
INTERVENTIONAL
2023-06-05
2024-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this two-arm parallel pilot study, it is the general practitioners that will be recruited to be in either arm. In the intervention group, they will deliver the multi-level intervention that consists of:
* Stratifying care based on the risk of chronicity
* Improving healthcare professional education
* Improving patient education
* Facilitating interprofessional communication
General practitioners in the control group will have no specific training or intervention. They will treat patients according to their usual practice.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective, Randomized Study of the Impact of a Education Program for Patients Suffering From Low Back Pain
NCT02564185
Effectiveness of Coordinated Care to Reduce the Prolonged Disability Risk Among Patients Suffering From Low Back Pain in Primary Care
NCT04826757
Effect of Physiotherapy in Patients Presenting to the Emergency Department With Nonspecific Lower Back Pain
NCT05156957
A Multilevel Intervention for Low Back Pain Management in Primary Care
NCT07137065
Improvement After Physiotherapy for Low Back Pain: The Good Responders
NCT02168582
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this pilot trial, it is the GPs that will be recruited to be in either arm. Five to seven GPs will be recruited in each study arm. As this is a pilot study, randomization was not felt necessary. To facilitate this pilot study, two health care centers (one for each arm) have been selected for their convenience. GPs from each arm will thus be recruited within the same health care center.
For the development of the intervention, various existing interventions that have been tested successfully elsewhere and had the possibility of being adapted in the context of Switzerland's primary care practice were selected. The investigators used available evidence to develop the multi-level intervention. The different components and the procedures of the multi-level intervention were developed by a team of LBP experts in collaboration with GPs, PTs, and OTs. Various meetings with GPs were conducted to determine the feasibility and their preferences for each component of the intervention.
The overall goal of the intervention is to help GPs provide high-value care, adapt the treatment plan to the risk of chronicity (stratified care), decrease unnecessary healthcare (i.e., unnecessary imaging), and facilitate interprofessional collaboration. The intervention includes the following components:
1. Stratifying the management of LBP according to risk factors for chronicity with the StartBack tool (SBT) has been shown to improve patient outcomes and reduce unnecessary overtreatment. This stratification into 3 stages, low, medium, and high, is mainly based on the presence of elements such as kinesiophobia and catastrophism. These elements are linked to anxiety, which is often involved in the erroneous prescription of imaging or inappropriate care (e.g. opioids). Thus, by adapting management to psychological factors it is possible to facilitate the reduction of unnecessary care together with the improvement of patients' outcomes. Based on previous work, the investigators developed a simple algorithm to determine the risk level based on the SBT and other variables that have been shown to improve the classification, such as work capacity. Based on the risk level, a management plan is proposed which may include PT.
PTs in the intervention group will all have participated to a one-day course to upgrade their knowledge on good clinical practice in LBP care and get the certification.
2. Healthcare professional education. The first component is health practitioners' education to improve their knowledge about LBP guidelines, diagnostic triage, and best practice. Furthermore, they will be trained to improve patients' education (i.e. on reducing the use of imaging), to follow a care strategy based on a questionnaire-based chronicity risk stratification rather than a step-up strategy, and improve interprofessional communication.
3. Patient education. Many patients expect to have an MRI of their spine in the belief that it will uncover the source of their problem and define the appropriate treatment. Only through better education can they change their perspective, be reassured of their clinical course without imaging, and understand the utility of staying active. Different strategies will be implemented to reassure patients. First, an education booklet "Understanding My Low Back Pain", which showed promising results in reducing the use of imaging has been translated into French and will be used by GPs during their consultations. Second, GPs, PTs, and OTs will provide similar reassuring messages and direct patients to the website www.infomaldedos.ch, which provides accurate and reassuring messages about LBP.
4. Interprofessional collaboration. By improving communication between the different healthcare providers, patients will have access to the right care at the right time and will receive a more consistent and reassuring message about LBP. To this end, a structured assessment form and facilitated contact will be implemented. PTs and OTs will be trained to provide a simple structured report of the patient's progress with a suggestion for further management to the GPs.
The multi-level intervention will be only at the level of the GPs. Prior to the start of the study, GPs will be informed on all aspects of good clinical practice during a specific time dedicated to continuing medical education. This will be done in interactive sessions, starting from their own experience, and implementing specific information when needed. A clinical pathway according to the risk of chronicity and specifically adapted to the Swiss healthcare system will be discussed during two one-hour meetings. The education will be provided by a rheumatologist with internationally recognized experience in the management of LBP. An information meeting will then be held to explain in detail the mechanisms of the study and the different tools that will be provided.
At the time of patient's first consultation for a new episode of back pain, The GP will have access to an interactive specifically designed and validated booklet in French "Understanding My Low Back Pain" to help educate patients that imaging is not recommended and point towards the general principle of good clinical practice care.
After the medical consultation, When the patient returns the signed informed consent form, the medical assistant will tag the patient within the computer system. Five days after the medical consultation the patient will receive an email with a questionnaire including the SBT. GPs will receive via email a summary of the SBT indicating the risk of chronicity (low, medium, or high) and a proposed treatment approach based on stratified care. The risk assessment will be based on the validated SBT with the addition of the ability to work.
In the case of low-risk GP'a are encouraged to focus on information and reassurance, with the help of information on a website. The use of additional treatments should be reduced to a minimum. In the case of medium risk, the proposition will be to prescribe 6 individual sessions of exercise-based physiotherapy. At the end of the 6 sessions, the physiotherapist will provide the GP with a structured report of the patient's progress with a suggestion for further management based on the clinical course: end of treatment, continuation for a few more sessions, or referral for further assessment to consider the need for structured multidisciplinary intervention. In cases of high risk, patients will be referred for 1-2 sessions to a specifically trained occupational therapist to determine if there is a need for immediate integration in a structured multidisciplinary group intervention or if the patient can be treated according to the proposition for medium risk patients. GPs are free to organize the following appointment and treatment plan according to the proposition or not.
Six weeks later, a second email will be sent to the patients with the same set of questionnaires and the updated results, including the updated risk of chronicity, will be sent to the GPs again. GPs may use this information to adapt patient care.
During the entire process, the decision on how to treat the patients is in the hand of the treating GPs. It is his responsibility to follow the recommendation of the proposed clinical pathway or not.
GPs in the control group will have no specific training or intervention. They will treat patients according to their usual practice. The same information will be provided to patients in the informed consent form (i.e. participation in a study on back pain). Patients will receive the same SMS to verify their phone number and then receive the same questionnaire as in the "stratified care" group. However, no feedback will be provided to the GPs.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Multi-level intervention
General practioners in this arm will receive the multi-level intervention composed of Stratified care, Healthcare professional education, Patient education and Interprofessional collaboration.
Implementation of best practice for low back pain in primary care
1. Stratified care: GPs will use a simple algorithm based on the risk of chronicity to determine the management plan. The risk level bas will be based on the Start Back Tool (SBT) and other variables that have been shown to improve the classification, such as work capacity.
2. Healthcare professional education: GPs will receive education to improve their knowledge about low back pain guidelines, diagnostic triage, patient education, stratified care and best practice.
3. Patient education: An education booklet "Understanding My Low Back Pain" will be used by GPs during their consultations. Second, GPs, PTs and OTs will provide similar reassuring messages and direct patients to the website www.infomaldedos.ch.
4. Interprofessional collaboration: A structured assessment form and a facilitated contact will be implemented between healthcare providers.
Usual care
GPs in the control group will have no specific training or intervention. They will treat patients according to their usual practice.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Implementation of best practice for low back pain in primary care
1. Stratified care: GPs will use a simple algorithm based on the risk of chronicity to determine the management plan. The risk level bas will be based on the Start Back Tool (SBT) and other variables that have been shown to improve the classification, such as work capacity.
2. Healthcare professional education: GPs will receive education to improve their knowledge about low back pain guidelines, diagnostic triage, patient education, stratified care and best practice.
3. Patient education: An education booklet "Understanding My Low Back Pain" will be used by GPs during their consultations. Second, GPs, PTs and OTs will provide similar reassuring messages and direct patients to the website www.infomaldedos.ch.
4. Interprofessional collaboration: A structured assessment form and a facilitated contact will be implemented between healthcare providers.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient consulting a general practitioner for a new episode of LBP
* Patients is part of "Delta Network"
Exclusion Criteria
* Patients unable to give consent and/or unable to answer the questionnaires, i.e. due to Dementia or language difficulties
* Known pregnancy
* Unable or unwilling to provide either a smartphone number or an email address.
* Unable or unwilling to give informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Haute Ecole de Santé Vaud
OTHER
Delta SA
UNKNOWN
University of Applied Sciences of Western Switzerland
OTHER
smarter medicine choosing wisely Switzerland
UNKNOWN
University Hospital, Geneva
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stephane Genevay
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stéphane Genevay, Prof
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Geneva
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre médical Lignon
Le Lignon, Canton of Geneva, Switzerland
Centre médical Onex
Onex, Canton of Geneva, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-00199
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.